Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy

BACKGROUND: Cardiovascular protection following empagliflozin therapy is not entirely attributable to the glucose lowering effect. Increased hematocrit might influence the shear stress that is the main force acting on the endothelium, regulating its anti-atherogenic function. OBJECTIVE: We designed...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cardiovasc Diabetol
Main Authors: Irace, Concetta, Casciaro, Francesco, Scavelli, Faustina Barbara, Oliverio, Rosa, Cutruzzolà, Antonio, Cortese, Claudio, Gnasso, Agostino
格式: Artigo
語言:Inglês
出版: BioMed Central 2018
主題:
Original Investigation
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5891980/
https://ncbi.nlm.nih.gov/pubmed/29631585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-018-0695-y
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍